To inhibit or enhance? Is there a benefit to positive allosteric modulation of P2X receptors?

Stokes, Leanne ORCID: https://orcid.org/0000-0003-4013-6781, Bidula, Stefan ORCID: https://orcid.org/0000-0002-3790-7138, Bibič, Lučka and Allum, Elizabeth (2020) To inhibit or enhance? Is there a benefit to positive allosteric modulation of P2X receptors? Frontiers in Pharmacology, 11. ISSN 1663-9812

[thumbnail of Published_Version]
Preview
PDF (Published_Version) - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

The family of ligand-gated ion channels known as P2X receptors were discovered several decades ago. Since the cloning of the seven P2X receptors (P2X1-P2X7), a huge research effort has elucidated their roles in regulating a range of physiological and pathophysiological processes. Transgenic animals have been influential in understanding which P2X receptors could be new therapeutic targets for disease. Furthermore, understanding how inherited mutations can increase susceptibility to disorders and diseases has advanced this knowledge base. There has been an emphasis on the discovery and development of pharmacological tools to help dissect the individual roles of P2X receptors and the pharmaceutical industry has been involved in pushing forward clinical development of several lead compounds. During the discovery phase, a number of positive allosteric modulators have been described for P2X receptors and these have been useful in assigning physiological roles to receptors. This review will consider the major physiological roles of P2X1-P2X7 and discuss whether enhancement of P2X receptor activity would offer any therapeutic benefit. We will review what is known about identified compounds acting as positive allosteric modulators and the recent identification of drug binding pockets for such modulators.

Item Type: Article
Uncontrolled Keywords: p2x receptor,p2x4,p2x7,allosteric modulator,drug discovery,pharmacology,pharmacology,pharmacology (medical) ,/dk/atira/pure/subjectarea/asjc/3000/3004
Faculty \ School: Faculty of Science > School of Pharmacy
Faculty of Science > School of Biological Sciences
UEA Research Groups: Faculty of Science > Research Groups > Molecular and Tissue Pharmacology
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 29 May 2020 00:28
Last Modified: 26 Nov 2023 02:54
URI: https://ueaeprints.uea.ac.uk/id/eprint/75377
DOI: 10.3389/fphar.2020.00627

Actions (login required)

View Item View Item